Bestselling Biotinylated Human Cd30/tnfrsf8 Protein (cd3-hm430b) Series [TbdwBnDq]

Biotinylated Human CD30/TNFRSF8 Protein

The Bestselling Biotinylated Human Cd30/tnfrsf8 Protein (cd3-hm430b) Series [TbdwBnDq] is a high-quality recombinant protein designed for research applications. This exceptional protein is biotinylated, offering increased affinity and specificity for streptavidin, which is invaluable for various research techniques such as immunoprecipitation and ELISA. The CD30/TNFRSF8 protein is expressed in a mammalian expression system, ensuring optimal functionality and bioactivity.

• High Affinity and Specificity: Biotinylated, enhancing binding to streptavidin
• Mammalian Expression: Ensures optimal functionality and bioactivity
• Research Applications: Ideal for immunoprecipitation, ELISA, and more

Product Properties and Specifications

Our Biotinylated Human CD30/TNFRSF8 Protein is rigorously tested for purity and activity. It is produced through a proprietary expression system, guaranteeing a consistent and reliable product. The protein is provided in a lyophilized form, which is convenient for storage and shipping. Additionally, it undergoes extensive quality control to ensure it meets the highest standards of purity and quality.

• Purity: ≥95% by SDS-PAGE
• Activity: Demonstrated by ELISA and other in vitro assays
• Storage: Lyophilized powder, stable at -20°C for 12 months

Practical Uses and Benefits

The Biotinylated Human CD30/TNFRSF8 Protein is an essential tool for researchers studying the CD30/TNFRSF8 pathway, which plays a crucial role in various biological processes. This protein is particularly useful in immunology, oncology, and cell signaling research. Its practical applications include the development of diagnostic tools, the study of cell signaling pathways, and the identification of potential therapeutic targets.

• Immunology Research: Investigating the role of CD30 in immune responses
• Oncology Research: Studying CD30 expression in various cancers and potential therapies
• Cell Signaling Research: Understanding the molecular mechanisms of CD30/TNFRSF8 signaling